Therapeutic Research Protocol Dose: 5 10 mg (variant 10 mg pen = 100200 clicks) Duration: 4 6 weeks loading, then taper Frequency: Split into 2 3 weekly injections Cycle Interval: 4 6 weeks off before repeating Goal / Description: Higher-dose protocol used in connective tissue and musculoskeletal injury models
See our detailed breakdown in GHK-Cu vs NAD+: A Clinical Comparison of Two Longevity Peptide Therapies
By enhancing angiogenesis: Nutrients and oxygen reach damaged tissues faster Inflammatory byproducts are cleared more efficiently Regeneration speed increases across soft tissue, joints, and muscle BPC-157 promotes angiogenesis and capillary density in damaged tissues through modulation of VEGF and endothelial nitric oxide synthase (eNOS). Sikiric et al., Regenerative Pharmacology 2
The critical transition point is the first needle puncture
Additionally, although not performed on fasting serum samples, the triglyceride concentration also improved in parallel to A 1c
At 24 hr of reperfusion in stroke rats, BPC 157treated rats maintained an unimpaired ability to resist lateral pushes (Figure 3), unlike the controls, which all lacked resistance to lateral pushes from either side of the shoulder
